Detection of necrotic malignant tissue and associated therapy

Details Detection of necrotic malignant tissue and associated therapy Detection of necrotic malignant tissue and associated therapy

1999-08-09

2000-06-06

Dees, Jose' G.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Attached to antibody or antibody fragment or immunoglobulin;...

424 111, 424 92, 4241411, A61K 5100, A61M 3614

Patent

active

060714913

ABSTRACT:
Disclosed are methods for identifying the presence of a tumor in a mammal, comprising the steps of obtaining an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled with a label capable of being imaged; administering the antibody to the mammal, thereby permitting the antibody to bind preferentially to necrotic tissue; and imaging the binding of the antibody to the necrotic tissue, wherein a localized concentration of said antibody is indicative of the presence of a tumor. The antibodies used in these methods are preferably monoclonal antibodies, are also preferably specific for one or more nuclear proteins, and are also preferably labeled with one or more radionuclides. Also disclosed are antibodies for use with the foregoing methods.

REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4444744 (1984-04-01), Goldenberg
patent: 4460559 (1984-07-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4499183 (1985-02-01), Sujansky et al.
patent: 4613576 (1986-09-01), Cote et al.
patent: 4628027 (1986-12-01), Gay
patent: 4693966 (1987-09-01), Houghton et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4735210 (1988-04-01), Goldenberg
patent: 4798790 (1989-01-01), Thomson et al.
patent: 4861581 (1989-08-01), Epstein et al.
patent: 5011920 (1991-04-01), Hakomori et al.
patent: 5019368 (1991-05-01), Epstein et al.
patent: 5130116 (1992-07-01), Woo et al.
patent: 5882626 (1999-03-01), Epstein et al.
Epstein, A. and Clevenger, C. in Progress in Non-Histone, Protein Research, Bekhor (Ed.) CRC Press, Boca Raton, 1985, pp. 117-137.
Clevenger, C. and Epstein, A. (1984), Exper. Cell Res. 151, 194-207.
Clevenger, C. and Epstein, A. (1984), J. Histochem. and Cytochem, 32(7), 757-765.
Beller, G. et al., (1977), Circulation 55(1), 74-78.
Murao, S. et al., (1985), Cancer Res. 45, 791-795.
Bauer, K. et al., (1986), J of Histochem. and Cytochem, 34(2), 245-250.
Clevenger, C. et al., (1985), Cytometry 6, 208-214.
Bauer, K. et al., (1986), Cancer Res. 46, 2428-2434.
Chose, T. et al., (1975), Europ. J. Cancer 11, 321-326.
Pelham, J. et al., (1983), Cancer Immunol. Immunother. 15, 210-216.
Deguchi, T. et al., (1986), Cancer Res. 46, 3751-3755.
Hurwitz, E. et al., (1975), Cancer Res. 35, 1176-1181.
Marchalonis, J., (1969), Biochem, J. 113, 299-305.
Khaw, B. et al., (1976), J. Clin. Invest. 58, 439-446.
Khaw, B. et al., (1979), Circulation 60, 1527-1531.
Centocor: Product Brocheure (SNM 1986), "Cardiac Patient Management".
Centocor: Product Brochure (SNM 1986), "Tumor Imaging with Monoclonal Antibodies: Ovarian and Breast CA.".
Centocor: Product Brochure (SNM 1986), "Thrombus Detection with Monoclonal Antibodies".
Cooper et al., Cell Death in Normal and Malignant Tissues., Adv. Cancer Research, 21:59-120, 1975.
Khaw et al., Myocardial Damage Delineated by Indium-111 Antimyosin Fab and Technetium-99m Pyrophosphate, J. Nucl. Med. 28: 76-82 (1987).
Carter et al., Inflammatory Changes in Tumour Vessel After Systemic 5-Hydroxytryptamine, Bradykinin, Kallikrein, or Lysolecithin. Br., J. Cancer 20:517-525, 1966.
Thomlinson et al., The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy, Br. J. Cancer 9:539-549, 1955.
Morgan et al., Monoclonal Antibody Therapy of Cancer: Preclinical Models and Investigations in Humas, In: R. Herberman (ed.), Cancer Immunology: Innovative Approaches to Therapy, pp. 177-200, Boston, MA: Martinium Nijhoff Publishers, 1986.
G. G. Stell, "Cell Loss as a Factor in the Growth Rate of Human Tumours," pp. 381-387, (1967).
I. F. Tannock, "The Relations Between Cell Proliferation and the Vascular System in a Transplanted Mouse Mammary Tumour", pp. 258-272,(1968).
E. H. Cooper, "The Biology of Cell Death in Tumours", Cell Tissue Kinet., pp. 87-95 (1973).
T. G. Fulghum et al., Clinical Research, vol. 31, No. 2, p. 459A (1983).

Affiliated with

Also associated with

Rating

Detection of necrotic malignant tissue and associated therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of necrotic malignant tissue and associated therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of necrotic malignant tissue and associated therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2211121